Physician profile
Brian Chao
NPI 1699267005
$6,528.16
in general payments reported to CMS, 2019-2025
6 companies · $4,262 in 2025
The $4,262 reported for 2025 was more than what 89% of Urology providers received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $2,238 · 2024: $27.60 · 2025: $4,262.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $3,265 · Food and Beverage: $1,763 · Education: $1,500.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $3,265.40 |
| Food and Beverage | $1,762.76 |
| Education | $1,500.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $3,757.89 | 2023-2025 | General - Erectile Dysfunction, Ams 800 Artificial Urinary Sphincter, Rezum Generator |
| Intuitive Surgical, INC. | $2,537.70 | 2025 | |
| Olympus America INC. | $150.00 | 2023 | Itind System |
| Glaxosmithkline, LLC. | $34.69 | 2025 | Shingrix |
| Merck Sharp & Dohme LLC | $27.60 | 2024 | Keytruda |
| Sumitomo Pharma America, INC. | $20.28 | 2023 | Gemtesa |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brian Chao listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.